USANA Health Sciences Inc (USNA) stock
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Oct 3, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.54+0.30 (+2.27%)
Close on Nov 16, 2026Market cap $250.17MP/E –Yield –
USANA Health Sciences total assets
Total assets on the balance sheet at the end of each period.
USANA Health Sciences's total assets was $708.47M at Oct 3, 2026. For fiscal 2025 it was $742.92M, down 0.7% from the year before. Over ten years it grew 5.8% a year on average. The highest annual figure on record is $748.19M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $742.92M | -0.7% |
| FY2024 | Dec 28, 2024 | $748.19M | +18.2% |
| FY2023 | Dec 30, 2023 | $632.76M | +6.1% |
| FY2022 | Dec 31, 2022 | $596.55M | +3.3% |
| FY2021 | Jan 1, 2022 | $577.74M | -9.9% |
| FY2020 | Jan 2, 2021 | $640.89M | +24.0% |
| FY2019 | Dec 28, 2019 | $516.93M | -6.8% |
| FY2018 | Dec 29, 2018 | $554.46M | +6.8% |
| FY2017 | Dec 30, 2017 | $519.27M | +10.3% |
| FY2016 | Dec 31, 2016 | $470.64M | +11.2% |
| FY2015 | Jan 2, 2016 | $423.24M | +20.7% |
| FY2014 | Jan 3, 2015 | $350.58M | -4.9% |
| FY2013 | Dec 28, 2013 | $368.47M | +37.8% |
| FY2012 | Dec 29, 2012 | $267.36M | +9.3% |
| FY2011 | Dec 31, 2011 | $244.50M | +12.9% |
| FY2010 | Jan 1, 2011 | $216.64M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Oct 3, 2026 | $708.47M | -2.5% |
| Q2 FY2026 | Jul 4, 2026 | $703.21M | -4.3% |
| Q1 FY2026 | Apr 4, 2026 | $738.97M | -1.0% |
| Q4 FY2025 | Jan 3, 2026 | $742.92M | -0.7% |
| Q3 FY2025 | Sep 27, 2025 | $726.59M | +8.2% |
| Q2 FY2025 | Jun 28, 2025 | $734.53M | +16.3% |
| Q1 FY2025 | Mar 29, 2025 | $746.60M | +18.6% |
| Q4 FY2024 | Dec 28, 2024 | $748.19M | +18.2% |
| Q3 FY2024 | Sep 28, 2024 | $671.31M | +11.7% |
| Q2 FY2024 | Jun 29, 2024 | $631.42M | +4.8% |
| Q1 FY2024 | Mar 30, 2024 | $629.28M | +3.9% |
| Q4 FY2023 | Dec 30, 2023 | $632.76M | +6.1% |
| Q3 FY2023 | Sep 30, 2023 | $601.15M | +8.1% |
| Q2 FY2023 | Jul 1, 2023 | $602.68M | +8.0% |
| Q1 FY2023 | Apr 1, 2023 | $605.53M | +5.7% |
| Q4 FY2022 | Dec 31, 2022 | $596.55M | +3.3% |
| Q3 FY2022 | Oct 1, 2022 | $556.06M | -4.0% |
| Q2 FY2022 | Jul 2, 2022 | $557.96M | -5.7% |
| Q1 FY2022 | Apr 2, 2022 | $572.92M | -2.0% |
| Q4 FY2021 | Jan 1, 2022 | $577.74M | -9.9% |
| Q3 FY2021 | Oct 2, 2021 | $578.95M | +0.2% |
| Q2 FY2021 | Jul 3, 2021 | $591.45M | +15.5% |
| Q1 FY2021 | Apr 3, 2021 | $584.51M | +23.4% |
| Q4 FY2020 | Jan 2, 2021 | $640.89M | +24.0% |
| Q3 FY2020 | Sep 26, 2020 | $577.53M | +24.7% |
| Q2 FY2020 | Jun 27, 2020 | $512.15M | -3.8% |
| Q1 FY2020 | Mar 28, 2020 | $473.75M | -14.1% |
| Q4 FY2019 | Dec 28, 2019 | $516.93M | -6.8% |
| Q3 FY2019 | Sep 28, 2019 | $463.04M | -22.7% |
| Q2 FY2019 | Jun 29, 2019 | $532.40M | -7.5% |
| Q1 FY2019 | Mar 30, 2019 | $551.58M | +1.0% |
| Q4 FY2018 | Dec 29, 2018 | $554.46M | +6.8% |
| Q3 FY2018 | Sep 29, 2018 | $599.38M | +22.2% |
| Q2 FY2018 | Jun 30, 2018 | $575.28M | +9.6% |
| Q1 FY2018 | Mar 31, 2018 | $545.95M | +15.7% |
| Q4 FY2017 | Dec 30, 2017 | $519.27M | +10.3% |
| Q3 FY2017 | Sep 30, 2017 | $490.65M | – |
| Q2 FY2017 | Jul 1, 2017 | $524.78M | – |
| Q1 FY2017 | Apr 1, 2017 | $472.01M | – |
| Q4 FY2016 | Dec 31, 2016 | $470.64M | – |
See a number that looks wrong?